{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:59:54Z","timestamp":1789423194491,"version":"build-2803163510"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.clim.2022.108931","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T14:53:23Z","timestamp":1642604003000},"page":"108931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Health-related quality of life in primary immunodeficiencies: Impact of delayed diagnosis and treatment burden"],"prefix":"10.1016","volume":"236","author":[{"given":"John T.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juthaporn","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Condino-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhransu","family":"Prusty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2022.108931_bb0010","doi-asserted-by":"crossref","first-page":"e1138","DOI":"10.1002\/cti2.1138","article-title":"Screening for primary immunodeficiency diseases by next-generation sequencing in early life","volume":"9","author":"Sun","year":"2020","journal-title":"Clin. Transl. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12026-018-8996-5","article-title":"Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell centers network on disease classification, regional trends, treatment modalities, and physician reported outcomes","volume":"66","author":"Modell","year":"2018","journal-title":"Immunol. Res."},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0020","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/CMR.00001-09","article-title":"Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections","volume":"22","author":"Fried","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"issue":"Suppl. 2","key":"10.1016\/j.clim.2022.108931_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13223-018-0290-5","article-title":"Primary immunodeficiency","volume":"14","author":"McCusker","year":"2018","journal-title":"Allergy, Asthma Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10875-009-9357-x","article-title":"Selective IgA deficiency","volume":"30","author":"Yel","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2022.108931_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01439","article-title":"Changing the lives of people with primary Immunodeficiencies (PI) with early testing and diagnosis","volume":"9","author":"Condino-Neto","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2022.108931_bb0040","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1542\/peds.2009-3659","article-title":"Why newborn screening for severe combined immunodeficiency is essential: a case report","volume":"126","author":"Adeli","year":"2010","journal-title":"Pediatrics."},{"issue":"5","key":"10.1016\/j.clim.2022.108931_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233342","article-title":"Evaluation of awareness about primary immunodeficiencies among physicians before and after implementation of the educational program: a longitudinal study","volume":"15","author":"Hariyan","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4065\/84.1.16","article-title":"Incidence and temporal trends of primary immunodeficiency: a population-based cohort study","volume":"84","author":"Joshi","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.clim.2022.108931_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13223-015-0092-y","article-title":"Health-related quality of life in patients with primary immunodeficiency disease","volume":"11","author":"Jiang","year":"2015","journal-title":"Allergy, Asthma Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2022.108931_bb0060","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/cei.12485","article-title":"Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease","volume":"179","author":"Jolles","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/cei.12915","article-title":"When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach","volume":"188","author":"Jolles","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2022.108931_bb0070","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10875-020-00841-3","article-title":"Immunoglobulin replacement therapy versus antibiotic prophylaxis as treatment for incomplete primary antibody deficiency","volume":"41","author":"Smits","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2022.108931_bb0075","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fimmu.2014.00627","article-title":"Primary immune deficiencies - principles of care","volume":"5","author":"Chapel","year":"2014","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2022.108931_bb0080","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/1744666X.2020.1801422","article-title":"Global systematic review of primary immunodeficiency registries","volume":"16","author":"Abolhassani","year":"2020","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-012-9751-7","article-title":"Primary immunodeficiency diseases worldwide: more common than generally thought","volume":"33","author":"Bousfiha","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2022.108931_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8416124","article-title":"Global distribution of common variable immunodeficiency (CVID) in the light of the UNDP human development index (HDI): a preliminary perspective of a rare disease","volume":"2020","author":"Weifenbach","year":"2020","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/cei.13125","article-title":"The United Kingdom primary immune deficiency (UKPID) registry 2012 to 2017","volume":"192","author":"Shillitoe","year":"2018","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000301584","article-title":"Change in referral diagnoses and diagnostic delay in hypogammaglobulinaemic patients during 28 years in a single referral Centre","volume":"153","author":"Litzman","year":"2010","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.clim.2022.108931_bb0105","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1590\/1806-9282.62.06.530","article-title":"Primary hypogammaglobulinemia: the impact of early diagnosis in lung complications","volume":"62","author":"Dorna","year":"2016","journal-title":"Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira."},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2022.108931_bb0115","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3389\/fimmu.2019.01272","article-title":"The German national registry of primary immunodeficiencies (2012-2017)","volume":"10","author":"El-Helou","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/cei.12661","article-title":"The Swiss National Registry for primary Immunodeficiencies: report on the first 6 years\u2019 activity from 2008 to 2014","volume":"182","author":"Marschall","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2022.108931_bb0125","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s10875-014-0066-8","article-title":"Primary immunodeficiency diseases: a 30-year patient registry from the referral center for primary immunodeficiencies in Greece","volume":"34","author":"Michos","year":"2014","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0130","first-page":"13","article-title":"Clinical-epidemiological pattern of primary Immunodeficiencies in Malaysia 1987-2006: a 20 year experience in four Malaysian hospitals","volume":"68","author":"Noh","year":"2013","journal-title":"Med J Malaysia"},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2022.108931_bb0135","first-page":"8","article-title":"Is there a delay in the diagnosis of PrimaryImmunodeficiency (PID)\u202f?","volume":"160","author":"Grigoriadou","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2022.108931_bb0140","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10875-019-00666-9","article-title":"How to identify common variable immunodeficiency patients earlier: general practice patterns","volume":"39","author":"Ilkj\u00e6r","year":"2019","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0145","first-page":"305","article-title":"Clinical and genetic study of X-linked Agammaglobulinemia patients (the benefit of early diagnosis)","volume":"19","author":"Alizadeh","year":"2020","journal-title":"Iran J. Allergy Asthma Immunol."},{"issue":"694","key":"10.1016\/j.clim.2022.108931_bb0150","article-title":"Delayed diagnosis and complications of predominantly antibody deficiencies in a cohort of Australian adults","volume":"9","author":"Slade","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2022.108931_bb0155","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s10875-018-0556-1","article-title":"Fourth update on the Iranian national registry of primary immunodeficiencies: integration of molecular diagnosis","volume":"38","author":"Abolhassani","year":"2018","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108931_bb0160","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10875-014-0001-z","article-title":"Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry","volume":"34","author":"Aghamohammadi","year":"2014","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108931_bb0165","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jaci.2018.12.994","article-title":"Genetic diagnosis of primary immunodeficiencies: a survey of the French national registry","volume":"143","author":"Mahlaoui","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2022.108931_bb0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1749-6632.2011.06238.x","article-title":"Primary immune deficiency disorders in the South Pacific: the clinical utility of a customized genetic testing program in New Zealand","volume":"1238","author":"Ameratunga","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0175","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/08880018.2013.805346","article-title":"Primary immunodeficiency disorders in the developing world: data from a hospital-based registry in India","volume":"31","author":"Chinnabhandar","year":"2014","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10875-011-9636-1","article-title":"Survival and predictors of death among primary immunodeficient patients: a registry-based study","volume":"32","author":"Al-Herz","year":"2012","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jmii.2011.01.026","article-title":"Impact of delayed diagnosis in children with primary antibody deficiencies","volume":"44","author":"Aghamohammadi","year":"2011","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"2","key":"10.1016\/j.clim.2022.108931_bb0190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.clim.2022.108931_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2017.03.011","article-title":"Delay in diagnosis affects the clinical outcome in a cohort of cvid patients with marked reduction of IGA serum levels","volume":"180","author":"Graziano","year":"2017","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2010.09.010","article-title":"Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey","volume":"138","author":"Chan","year":"2011","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108931_bb0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/08820139.2016.1258710","article-title":"Measurement of health-related quality of life in primary antibody-deficient patients","volume":"46","author":"Ataeinia","year":"2017","journal-title":"Immunol. Investig."},{"issue":"2","key":"10.1016\/j.clim.2022.108931_bb0210","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1081-1206(10)61469-X","article-title":"Quality of life in common variable immunodeficiency requiring intravenous immunoglobulin therapy","volume":"93","author":"Tcheurekdjian","year":"2004","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"7","key":"10.1016\/j.clim.2022.108931_bb0215","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s10875-014-0072-x","article-title":"Quality of life in children with primary antibody deficiency","volume":"34","author":"Titman","year":"2014","journal-title":"J. Clin. Immunol."},{"issue":"149","key":"10.1016\/j.clim.2022.108931_bb0220","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0019-2018","article-title":"The broad spectrum of lung diseases in primary antibody deficiencies","volume":"27","author":"Cinetto","year":"2018","journal-title":"Eur. Respir. Rev."},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0225","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12026-017-8907-1","article-title":"Modeling strategy to identify patients with primary immunodeficiency utilizing risk management and outcome measurement","volume":"65","author":"Modell","year":"2017","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13023-018-0941-0","article-title":"The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data","volume":"13","author":"Odnoletkova","year":"2018","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0235","first-page":"47","article-title":"Health-related quality of life in primary antibody deficiency","volume":"10","author":"Aghamohammadi","year":"2011","journal-title":"Iran J. Allergy Asthma Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108931_bb0240","first-page":"400","article-title":"Clinical profile, dosing, and quality-of-life outcomes in primary immune deficiency patients treated at home with immunoglobulin G: data from the IDEaL patient registry","volume":"23","author":"Kearns","year":"2017","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"5","key":"10.1016\/j.clim.2022.108931_bb0245","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10875-017-0404-8","article-title":"Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment","volume":"37","author":"Rider","year":"2017","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0250","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12026-020-09131-x","article-title":"Jeffrey\u2019s insights: Jeffrey Modell Foundation\u2019s global genetic sequencing pilot program to identify specific primary immunodeficiency defects to optimize disease management and treatment","volume":"68","author":"Quinn","year":"2020","journal-title":"Immunol. Res."},{"key":"10.1016\/j.clim.2022.108931_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.2011.06206.x","article-title":"Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century","volume":"1238","author":"Arkwright","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0260","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10875-013-9954-6","article-title":"Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice","volume":"34","author":"Costa-Carvalho","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2022.108931_bb0265","author":"Jeffrey Modell Foundation (JMF)"},{"issue":"59","key":"10.1016\/j.clim.2022.108931_bb0270","first-page":"869","article-title":"Evaluation of the protein gap for detection of abnormal serum gammaglobulin level: an imperfect predictor","volume":"19","author":"Suleman","year":"2020","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0275","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/cei.12369","article-title":"Calculated globulin (CG) as a screening test for antibody deficiency","volume":"177","author":"Jolles","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2022.108931_bb0280","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12016-014-8412-4","article-title":"Laboratory diagnosis of primary immunodeficiencies","volume":"46","author":"Locke","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clim.2022.108931_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108359","article-title":"Cost and impact of early diagnosis in primary immunodeficiency disease: a literature review","volume":"213","author":"Elsink","year":"2020","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2022.108931_bb0290","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1586\/1744666X.2015.1029457","article-title":"Economic burden of common variable immunodeficiency: annual cost of disease","volume":"11","author":"Sadeghi","year":"2015","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"70","key":"10.1016\/j.clim.2022.108931_bb0295","article-title":"Calculation of a primary immunodeficiency \u201crisk vital sign\u201d via population-wide analysis of claims data to aid in clinical decision support","volume":"7","author":"Rider","year":"2019","journal-title":"Front. Pediatr."},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0300","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/ijns5030028","article-title":"A cost-effectiveness analysis of newborn screening for severe combined immunodeficiency in the UK","volume":"5","author":"Bessey","year":"2019","journal-title":"Int. J. Neonatal. Screen."},{"issue":"2406","key":"10.1016\/j.clim.2022.108931_bb0305","article-title":"First universal newborn screening program for severe combined immunodeficiency in Europe. Two-Years\u2019 experience in Catalonia (Spain)","volume":"10","author":"Argudo-Ram\u00edrez","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0310","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12026-020-09117-9","article-title":"The case for severe combined immunodeficiency (SCID) and T cell lymphopenia newborn screening: saving lives\u2026one at a time","volume":"68","author":"Quinn","year":"2020","journal-title":"Immunol. Res."},{"issue":"5","key":"10.1016\/j.clim.2022.108931_bb0315","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00431-019-03346-3","article-title":"Cost-effectiveness of newborn screening for severe combined immunodeficiency","volume":"178","author":"Van der Ploeg","year":"2019","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.clim.2022.108931_bb0320","author":"Centers for Disease Control and Prevention"},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0325","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12026-016-8784-z","article-title":"Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell centers global network","volume":"64","author":"Modell","year":"2016","journal-title":"Immunol. Res."},{"issue":"Pt 3","key":"10.1016\/j.clim.2022.108931_bb0330","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0004563214545791","article-title":"Using calculated globulin fraction to reduce diagnostic delay in primary and secondary hypogammaglobulinaemias: results of a demonstration project","volume":"52","author":"Holding","year":"2015","journal-title":"Ann. Clin. Biochem."},{"issue":"4","key":"10.1016\/j.clim.2022.108931_bb0335","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaci.2016.05.035","article-title":"Rapid molecular diagnostics of severe primary immunodeficiency determined by using targeted next-generation sequencing","volume":"138","author":"Yu","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0340","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10875-018-0489-8","article-title":"Use of genetic testing for primary immunodeficiency patients","volume":"38","author":"Heimall","year":"2018","journal-title":"J. Clin. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2022.108931_bb0345","doi-asserted-by":"crossref","DOI":"10.1097\/MOP.0000000000000834","article-title":"Diagnosis of primary immunodeficiency diseases in the developing world: the need for education and networking with the developed world","volume":"31","author":"Villavicencio","year":"2019","journal-title":"Curr. Opin. Pediatr."},{"issue":"5","key":"10.1016\/j.clim.2022.108931_bb0350","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.anai.2019.08.016","article-title":"Practical approach to genetic testing for primary immunodeficiencies","volume":"123","author":"Chinen","year":"2019","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.clim.2022.108931_bb0355","first-page":"9","article-title":"Recent advances in primary immunodeficiency: from molecular diagnosis to treatment","author":"Bucciol","year":"2020","journal-title":"F1000Res"},{"issue":"5","key":"10.1016\/j.clim.2022.108931_bb0360","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7861\/clinmedicine.18-5-364","article-title":"Immunoglobulin use in immune deficiency in the UK: a report of the UKPID and National Immunoglobulin databases","volume":"18","author":"Shillitoe","year":"2018","journal-title":"Clin. Med. (Lond.)"},{"issue":"23\u201324","key":"10.1016\/j.clim.2022.108931_bb0365","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1111\/jocn.14580","article-title":"\u201cexperiences of the burden of treatment\u201d-patient reports of facilitated subcutaneous immunoglobulin treatment in adults with immunodeficiency","volume":"27","author":"Petersson","year":"2018","journal-title":"J. Clin. Nurs."},{"issue":"8","key":"10.1016\/j.clim.2022.108931_bb0370","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s10875-018-0562-3","article-title":"Treatment satisfaction with subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency: a pooled analysis of six Hizentra\u00ae studies","volume":"38","author":"Mallick","year":"2018","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108931_bb0375","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10875-018-0507-x","article-title":"Rapid push vs pump-infused subcutaneous immunoglobulin treatment: a randomized crossover study of quality of life in primary immunodeficiency patients","volume":"38","author":"Bienvenu","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2022.108931_bb0380","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3389\/fimmu.2018.01308","article-title":"What is the burden of immunoglobulin replacement therapy in adult patients with primary Immunodeficiencies? A systematic review","volume":"9","author":"Jones","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0385","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/ped.14119","article-title":"The influence of hospital-based intravenous immunoglobulin and home-based self-administrated subcutaneous immunoglobulin therapy in young children with primary immunodeficiency diseases on their parents\u2019\/caregivers\u2019 satisfaction","volume":"62","author":"Lechanska-Helman","year":"2020","journal-title":"Pediatr. Int."},{"issue":"3","key":"10.1016\/j.clim.2022.108931_bb0390","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3349\/ymj.2012.53.3.603","article-title":"Health related quality of life in common variable immunodeficiency","volume":"53","author":"Quinti","year":"2012","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.clim.2022.108931_bb0395","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2147\/PPA.S60771","article-title":"Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment","volume":"8","author":"Espanol","year":"2014","journal-title":"Patient Prefer Adherence."},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0400","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13023-016-0452-9","article-title":"Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort \u201cvisages\u201d","volume":"11","author":"Bienvenu","year":"2016","journal-title":"Orphanet J Rare Dis."},{"issue":"2","key":"10.1016\/j.clim.2022.108931_bb0405","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10875-019-0592-5","article-title":"Health-related quality of life in patients with CVID under different schedules of immunoglobulin administration: prospective multicenter study","volume":"39","author":"Pulvirenti","year":"2019","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2022.108931_bb0410","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaip.2020.08.016","article-title":"Increased respiratory viral detection and symptom burden among patients with primary antibody deficiency: results from the BIPAD study","volume":"9","author":"Ponsford","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.clim.2022.108931_bb0415","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jaip.2019.02.013","article-title":"Health-related quality of life in children and adults with primary Immunodeficiencies: a systematic review and meta-analysis","volume":"7","author":"Peshko","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.clim.2022.108931_bb0420","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.jaci.2016.11.029","article-title":"Construction and validation of a novel disease-specific quality-of-life instrument for patients with primary antibody deficiency disease (PADQOL-16)","volume":"139","author":"Ballow","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2022.108931_bb0425","doi-asserted-by":"crossref","first-page":"AB13","DOI":"10.1016\/j.jaci.2018.12.042","article-title":"Evaluation of different treatments for specific antibody deficiency with normal immunoglobulins","volume":"143","author":"Pandya","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2022.108931_bb0430","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000503997","article-title":"Targeted therapy with biologicals and small molecules in primary Immunodeficiencies","volume":"29","author":"Delmonte","year":"2020","journal-title":"Med. Princ. Pract."},{"issue":"2\u20133","key":"10.1016\/j.clim.2022.108931_bb0435","first-page":"141","article-title":"Performance status and deaths among children registered in Kuwait National Primary ImmunoDeficiency disorders registry","volume":"28","author":"Al-Herz","year":"2010","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.clim.2022.108931_bb0440","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3389\/fimmu.2019.01754","article-title":"The Kuwait National Primary Immunodeficiency registry 2004-2018","volume":"10","author":"Al-Herz","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2022.108931_bb0445","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10875-015-0206-9","article-title":"Report of the Tunisian registry of primary Immunodeficiencies: 25-years of experience (1988-2012)","volume":"35","author":"Mellouli","year":"2015","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108931_bb0450","first-page":"459","article-title":"First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998-2012)","volume":"34","author":"Bousfiha","year":"2014","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2022.108931_bb0455","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/cei.12105","article-title":"The German national registry for primary immunodeficiencies (PID)","volume":"173","author":"Gathmann","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.108931_bb0460","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cei.12172","article-title":"The United Kingdom primary immune deficiency (UKPID) registry: report of the first 4 years\u2019 activity 2008-2012","volume":"175","author":"Edgar","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108931_bb0465","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10875-017-0398-2","article-title":"Diagnostic delay of primary Immunodeficiencies at a tertiary Care Hospital in Peru- Brief Report","volume":"37","author":"Veramendi-Espinoza","year":"2017","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108931_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175867","article-title":"Disease burden for patients with primary immunodeficiency diseases identified at reference hospitals in Guanajuato, Mexico","volume":"12","author":"Guan\u00ed-Guerra","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clim.2022.108931_bb0475","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.clim.2010.02.021","volume":"135","author":"The French National Registry of Primary Immunodeficiency Diseases","year":"2010","journal-title":"Clin. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:05:52Z","timestamp":1761494752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661622000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":95,"alternative-id":["S1521661622000110"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.108931","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-related quality of life in primary immunodeficiencies: Impact of delayed diagnosis and treatment burden","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.108931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108931"}}